Hanseatic Management Services Inc Bristol Myers Squibb CO Transaction History

Hanseatic Management Services Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	BUY	$68.48 - $81.09 $5,957 - $7,054	87 Added 6.03%	1,529 $110,000
Q3 2022 Nov 08, 2022	BUY	$0.13 - $76.84 $8 - $5,225	68 Added 4.95%	1,442 $103,000
Q2 2022 Aug 05, 2022	BUY	$72.62 - $79.98 $99,779 - $109,892	1,374 New	1,374 $106,000
Q4 2020 Jan 29, 2021	SELL	$57.74 - $65.43 $57,797 - $65,495	-1,001 Closed	0 $0
Q3 2020 Oct 29, 2020	SELL	$57.43 - $63.64 $375,534 - $416,141	-6,539 Reduced 86.72%	1,001 $60,000
Q2 2020 Aug 10, 2020	BUY	$54.82 - $64.09 $12,718 - $14,868	232 Added 3.17%	7,540 $443,000
Q1 2020 Apr 22, 2020	BUY	$46.4 - $67.43 $35,681 - $51,853	769 Added 11.76%	7,308 $407,000
Q4 2019 Jan 29, 2020	BUY	$49.21 - $64.19 $321,784 - $419,738	6,539 New	6,539 $420,000
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $47,498 - $59,201	-940 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$59.92 - $68.98 $9,886 - $11,381	165 Added 21.29%	940 $59,000
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $46,453 - $50,646	775	775 $47,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

Stay updated on Hanseatic Management Services Inc with notifications on news.